Nav: Home

Study shows rising age of first drug use in teens, young adults

March 02, 2020

SPOKANE, Wash. - The average age at which teens and young adults start using drugs has been rising, according to a study published today in JAMA Pediatrics.

The study examined changes in the average age of first drug use for 18 different drugs--including alcohol and tobacco products--between 2004 and 2017 and found that average ages had increased for the majority of those drugs.

For example, the study showed that the average age at which young people first consumed alcohol or smoked cigarettes rose from 16 in 2004 to 17 in 2017. Those who reported using heroin or cocaine for the first time had an average age of just over 17 in 2004, which had risen to about 18 for heroin and close to 19 for cocaine by 2017.

"This is great news, because delaying drug use prevents early exposure, which is associated with a variety of negative health consequences, including increased risk of drug use disorder and long-term impairments such as depression, neurocognitive deficits, involvement in risky behaviors, and sexually transmitted diseases, said lead author Karl Alcover, a postdoctoral research associate in Washington State University's Elson S. Floyd College of Medicine.

In their study, the researchers used publicly available data collected as part of the National Survey on Drug Use and Health, an annual survey that looks at drug use in a representative sample of US residents aged 12 and older. They included data on 84,317 respondents between the ages of 12 and 21 who were surveyed between 2004 and 2017 and had reported first-time drug use in the previous 12 months.

The researchers analyzed the data to estimate the average age at first-time use for 18 internationally regulated drugs for each year included in the study. Looking at year-to-year trends, they found that the average age at first use had increased for 12 out of 18 drugs, including alcohol, cocaine, ecstasy, hallucinogens, heroin, inhalants, LSD, marijuana, stimulants, and tobacco products such as cigars, cigarettes and smokeless tobacco. For the other six drugs--crack cocaine, methamphetamines, opioids, PCP, sedatives, and tranquilizers--they found no statistically significant changes in the age at first use.

Increases were relatively consistent from year to year for all but two drugs: alcohol and LSD. In 2004, the average age at which young people first consumed alcohol was approximately 16 years. It increased consistently through 2014, after which it leveled off at about age 17 in 2017. The average age of first use of LSD increased significantly through 2014 and subsequently declined, but still showed an overall increase over the entire timeframe studied. These findings suggest that trends toward starting to use at a later age may have already ended for those two drugs, Alcover said.

The earliest average age of first drug use across the study timeframe was 15.4 for inhalants, whereas the latest average age was 18.0 for cocaine and crack cocaine.

"Our study shows that since 2004 fewer individuals started using drugs at age 15 and younger, which is what we would typically consider as early-onset drug use," Alcover said. "These promising trends may serve as early evidence that prevention strategies--especially those focused on teens and young adults--are working."

Alcover said the next step is to investigate what drives the trends seen in this study. The success of prevention efforts is one possible explanation, but it could also be that young people's preferences have switched to new drugs such as e-cigarettes, which were not included in the survey data. He also noted that further research should be done to understand why some drugs did not show an increase in average age, which could help improve prevention strategies for those drugs.

"Prevention of drug use is the best approach to reducing drug-related burden in the population," Alcover said.
-end-


Washington State University

Related Science Articles:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.
Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.
Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.
Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.
World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.
PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.
Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.
Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.
More Science News and Science Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.